Campbell & Co Investment Adviser’s CVS Health CVS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$402K	Sell	3,883 -27,755	-88%	-$2.48M	0.02%	835
2026 Q1	$2.27M	Buy	31,638 +15,033	+91%	+$1.16M	0.13%	241
2025 Q4	$1.32M	Buy	+16,605	New	+$1.31M	0.06%	454
2025 Q2	–	Sell	-24,270	Closed	-$1.64M	–	1190
2025 Q1	$1.64M	Buy	+24,270	New	+$1.45M	0.13%	252
2024 Q4	–	Sell	-4,964	Closed	-$312K	–	1109
2024 Q3	$312K	Buy	+4,964	New	+$290K	0.02%	886
2024 Q1	–	Sell	-13,900	Closed	-$1.1M	–	1147
2023 Q4	$1.1M	Buy	13,900 +5,210	+60%	+$371K	0.1%	347
2023 Q3	$607K	Buy	+8,690	New	+$616K	0.07%	434
2019 Q3	–	Sell	-17,397	Closed	-$948K	–	634
2019 Q2	$948K	Buy	+17,397	New	+$937K	0.43%	32
2015 Q4	–	Sell	-3,637	Closed	-$351K	–	111
2015 Q3	$351K	Buy	+3,637	New	+$382K	0.23%	155
2013 Q4	–	Sell	-140,284	Closed	-$7.96M	–	238
2013 Q3	$7.96M	Buy	+140,284	New	+$8.36M	1.56%	13

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Campbell & Co Investment Adviser's CVS Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its CVS Health (CVS) stake by 88% in Q2 2026, selling an estimated $2.48M and leaving 3,883 shares worth $402K. The position accounts for 0.02% of the portfolio, ranked #835.

Campbell & Co Investment Adviser first reported a position in CVS in Q3 2013 and has held it in 10 quarters since. The position peaked at $7.96M in Q3 2013. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Campbell & Co Investment Adviser held 3,883 shares of CVS Health worth $402K as of Q2 2026.
Campbell & Co Investment Adviser sold 27,755 CVS Health shares in Q2 2026, an estimated $2.48M.
CVS Health made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #835 holding.
Campbell & Co Investment Adviser first reported a position in CVS Health in Q3 2013 and has held it in 10 quarters since.
Campbell & Co Investment Adviser's CVS Health position peaked at $7.96M in Q3 2013.
2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.